Meadowhawk Biolabs, Inc.
Jim Jersey serves as the President and CEO of Meadowhawk Biolabs, Inc. since September 2021. Prior to this, Jim held various leadership roles at Agilux Laboratories Inc. for over a decade, including President and CEO. Jim holds a Ph.D. in ESE from the University of North Carolina at Chapel Hill, graduating in 1990.
Meadowhawk Biolabs, Inc.
Meadowhawk biolabs is a CRO that was created to make a difference for our pharmaceutical and biotech clients in drug discovery and development. Our curiosity, unwillingness to accept the status quo and unflagging commitment and alignment to our values drives us to partner with our clients to bring new treatments and therapeutics faster to patients.